Co-Diagnostics

+$0.06 (+0.78%) As of 4:30 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CEO
Dwight Howard Egan
Employees
37
Headquarters
Salt Lake City, Utah
Founded
2013

CODX Key Statistics

Market Cap
247.77M
Price-Earnings Ratio
5.31
Dividend Yield
—
Average Volume
268.33K
High Today
$8.45
Low Today
$8.25
Open Price
$8.31
Volume
140.93K
52 Week High
$20.69
52 Week Low
$7.01

CODX Earnings

-$0.05
$0.18
$0.40
$0.63
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure